Consistent with a reduction in the number of stem-like cancer cells, we observed that knockdown of ABCC3 led to reduced tumor growth compared to control NT cells, which was further reduced on doxorubicin treatment (Fig 7G, 7H and S8 Table). The gene discussed is ABCC3; the disease is neoplasm.